Your browser doesn't support javascript.
loading
Efficacy of diet restriction with or without probiotic for treatment of patients with IBS-D: Phase I-II clinical trial.
Zhao, Xian-Shu; Shi, Li-Jun; Ning, Bao-Li; Zhao, Zhi-Ming; Li, Xiao-Xue; Zhu, Meng-Hua; Zhang, Ya-Bing; Fu, Jun.
Affiliation
  • Zhao XS; Health Center of Screening and Prevention of Diseases, First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Shi LJ; Department of gastroenterology, First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Ning BL; Health Center of Screening and Prevention of Diseases, First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Zhao ZM; Health Center of Screening and Prevention of Diseases, First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Li XX; Department of gastroenterology, First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Zhu MH; Department of gastroenterology, First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Zhang YB; Department of gastroenterology, First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Fu J; Health Center of Screening and Prevention of Diseases, First Affiliated Hospital of Harbin Medical University, Harbin, China.
Immun Inflamm Dis ; 11(5): e857, 2023 05.
Article in En | MEDLINE | ID: mdl-37249280
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Probiotics / Irritable Bowel Syndrome Type of study: Clinical_trials Aspects: Patient_preference Limits: Humans Language: En Journal: Immun Inflamm Dis Year: 2023 Document type: Article Affiliation country: China Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Probiotics / Irritable Bowel Syndrome Type of study: Clinical_trials Aspects: Patient_preference Limits: Humans Language: En Journal: Immun Inflamm Dis Year: 2023 Document type: Article Affiliation country: China Country of publication: Reino Unido